These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16481094)

  • 21. Use of Duloxetine for Postprostatectomy Stress Urinary Incontinence: A Systematic Review.
    Kotecha P; Sahai A; Malde S
    Eur Urol Focus; 2021 May; 7(3):618-628. PubMed ID: 32605820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duloxetine in women awaiting surgery.
    Drutz H
    BJOG; 2006 May; 113 Suppl 1():17-21. PubMed ID: 16529565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duloxetine for the treatment of post-prostatectomy stress urinary incontinence.
    Neff D; Guise A; Guralnick ML; Langenstroer P; See WA; Jacobsohn KM; O'Connor RC
    Can Urol Assoc J; 2013; 7(5-6):E260-2. PubMed ID: 23766826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence.
    van Kerrebroeck P; Abrams P; Lange R; Slack M; Wyndaele JJ; Yalcin I; Bump RC;
    BJOG; 2004 Mar; 111(3):249-57. PubMed ID: 14961887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacologic treatment in postprostatectomy stress urinary incontinence.
    Filocamo MT; Li Marzi V; Del Popolo G; Cecconi F; Villari D; Marzocco M; Nicita G
    Eur Urol; 2007 Jun; 51(6):1559-64. PubMed ID: 16942833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacotherapy of stress incontinence].
    Jost WH; Marsalek P; Michel MC
    Dtsch Med Wochenschr; 2005 Oct; 130(41):2337-42. PubMed ID: 16231235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of duloxetine on female sexual functions in the treatment of stress incontinence.
    Biyikoglu M; Kettas E; Sesli M; Senel S; Cayan S; Akbay E
    Arch Gynecol Obstet; 2023 Sep; 308(3):1037-1042. PubMed ID: 37386151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Conservative treatment in male urinary incontinence].
    Kirschner-Hermanns R; Anding R
    Urologe A; 2014 Mar; 53(3):333-4, 336, 338. PubMed ID: 24585116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Duloxetine. A new preparation for patients with urinary incontinence].
    Walter S
    Ugeskr Laeger; 2005 Nov; 167(48):4553-5. PubMed ID: 16324435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duloxetine: in stress urinary incontinence.
    McCormack PL; Keating GM
    Drugs; 2004; 64(22):2567-73; discussion 2574-5. PubMed ID: 15516154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial management of stress urinary incontinence: pelvic floor muscle training and duloxetine.
    Freeman RM
    BJOG; 2006 May; 113 Suppl 1():10-6. PubMed ID: 16529564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacotherapy for stress urinary incontinence.
    Castro-Diaz D; Amoros MA
    Curr Opin Urol; 2005 Jul; 15(4):227-30. PubMed ID: 15928510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duloxetine versus placebo in the treatment of stress urinary incontinence.
    Norton PA; Zinner NR; Yalcin I; Bump RC;
    Am J Obstet Gynecol; 2002 Jul; 187(1):40-8. PubMed ID: 12114886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innovations in pharmacotherapy for stress urinary incontinence.
    Cannon TW; Yoshimura N; Chancellor MB
    Int Urogynecol J Pelvic Floor Dysfunct; 2003 Dec; 14(6):367-72. PubMed ID: 14676995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence.
    Zinner NR
    Expert Opin Investig Drugs; 2003 Sep; 12(9):1559-66. PubMed ID: 12943499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial.
    Lin AT; Sun MJ; Tai HL; Chuang YC; Huang ST; Wang N; Zhao YD; Beyrer J; Wulster-Radcliffe M; Levine L; Chang C; Viktrup L
    BMC Urol; 2008 Jan; 8():2. PubMed ID: 18221532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do predictive parameters exist for therapy with duloxetine in women with stress urinary incontinence?
    Schwertner-Tiepelmann N; Schwab F; Tunn R
    Int Urogynecol J; 2014 Aug; 25(8):1071-9. PubMed ID: 24604277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The treatment of urinary incontinence with Duloxetine.
    Basu M; Duckett J
    J Obstet Gynaecol; 2008 Feb; 28(2):166-9. PubMed ID: 18393011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of duloxetine in stress urinary incontinence: a systematic review and meta-analysis.
    Li J; Yang L; Pu C; Tang Y; Yun H; Han P
    Int Urol Nephrol; 2013 Jun; 45(3):679-86. PubMed ID: 23504618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological agents used for the treatment of stress urinary incontinence in women.
    Viktrup L; Bump RC
    Curr Med Res Opin; 2003; 19(6):485-90. PubMed ID: 14594520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.